Unknown

Dataset Information

0

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.

ABSTRACT:

SUBMITTER: Patel TK 

PROVIDER: S-EPMC7326306 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.

Patel Tejas K TK   Barvaliya Manish M   Kevadiya Bhavesh D BD   Patel Parvati B PB   Bhalla Hira Lal HL  

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20200902 3

Similar Datasets

Unknown Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review.
| S-EPMC7280684 | biostudies-literature
Unknown The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
| S-EPMC7717256 | biostudies-literature
Genomics Cardiometabolic MicroRNAs are Associated with severeerity and 28-Day Intensive Care Unit Mortality in COVID-19 Patients
2021-11-17 | GSE176498 | GEO
Unknown Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease.
| S-EPMC8943168 | biostudies-literature
Unknown Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19.
| S-EPMC7563535 | biostudies-literature
Unknown Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality.
| S-EPMC7675747 | biostudies-literature
Unknown Hydroxychloroquine and COVID-19.
| S-EPMC10016880 | biostudies-literature
Unknown Azvudine efficacy in reducing mortality in COVID-19 patients.
| S-EPMC11670479 | biostudies-literature
Unknown Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
| S-EPMC7906731 | biostudies-literature
Unknown No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison.
| S-EPMC8100580 | biostudies-literature